What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Scientific Project Manager_20240242 Codi 2024-242 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0242//2024_0242_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció ERN EuroBloodNet Projects Coordinator Codi 2024-243 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0243//2024_0243_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Project Manager_Registries Codi 2024-244 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0244//2024_0244_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Sat, 27 Jul 2024 - 12:00 Descripció Ethics Committees Administrative_20240245 Codi 2024-245 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0245//2024_0245_001.pdf Reclutant Inactiu Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Microbiome Research Descripció Research Technician Microbiome Research Group _20240246 Codi 2024-246 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0246//2024_0246_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Thu, 25 Jul 2024 - 12:00 Grup de recerca Rheumatology Descripció Clinical Research Monitor Rheumatology Research Group _20240240 Codi 2024-240 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0240//2024_0240_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Sun, 8 Sep 2024 - 12:00 Grup de recerca Basic, Translational and Clinical Pharmacy Research Descripció Call for Postdoctoral Junior Leader fellowships (Basic,Translational and Clinical Pharmacy Research Group)_20240241 Codi 2024-241 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0241//2024_0241_001.pdf Reclutant Inactiu Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Thu, 25 Jul 2024 - 12:00 Descripció Biddings Manager_20240239 Codi 2024-239 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0239//2024_0239_001.pdf Reclutant Inactiu Estudio de extensión, abierto de 52 semanas para evaluar la pimavanserina en niños y adolescentes con irritabilidad asociada al trastorno del espectro autista (TEA) Contact Protocol code: ACP-103-070 EudraCT code: 2021-005388-32 Pathology: Malalties del sistema nerviós Principal investigator: Gisbert Gustemps, Laura Research group: Psiquiatria, salut mental i addiccions Service: Psiquiatria Phase: Fase II Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, aleatorizado y controlado con placebo para evaluar la eficacia y la seguridad de MK-0616 para reducir las complicaciones cardiovasculares graves en participantes con riesgo cardiovascular elevado. Contact Protocol code: MK-0616-015 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Lozano Torres, Jordi Research group: Malalties cardiovasculars Service: Cardiologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Progressive Forms of Multiple Sclerosis (PMS) // Estudio fase I, multicéntrico, de brazo único, de aumento escalonado de la dosis de CC-97540 (BMS-986353), células T con receptor de antigénico quimérico (CAR-T) NEX-T dirigidas frente a CD19, para evaluar la seguridad y la tolerabilidad en participantes con formas recidivantes de esclerosis múltiple (EMR) o formas progresivas de esclerosis múltiple (EMP) Contact Protocol code: CA061-1006 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Montalban Gairín, Xavier Research group: Neuroimmunologia clínica Service: Neuroimmunologia Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Eficacia de duloxetina perioperatoria en pacientes con alto riesgo de desarrollar dolor crónico post-quirúrgico tras la cirugía de hernia inguinal: ensayo multicéntrico, aleatorizado y controlado Contact Protocol code: ICI21//00006l EudraCT code: No aplica Pathology: Factors que influencien en l’estat de salut i contacte amb els serveis de salut Principal investigator: Salgado Algaba, Inmaculada Service: Anestèsia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. “Estudio aleatorizado, doble ciego, controlado con placebo y degrupos paralelos para evaluar la eficacia y la seguridad a largo plazo de dupilumab enniños de 2 a <6 años con asma no controlada y/o sibilancias asmáticas gravesrecurrentes Contact Protocol code: EFC14771 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: de Mir Messa, Inés Research group: Creixement i desenvolupament Service: Pediatria General i Especialitats Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de extensión de fase IV, multicéntrico y abierto para pacientes con enfermedad de células falciformes que hayan completado un estudio anterior de crizanlizumab promocionado por Novartis Contact Protocol code: CSEG101A2401B EudraCT code: 2020-004225-22 Pathology: Tumors Principal investigator: Díaz de Heredia Rubio, Maria Cristina Research group: Childhood Cancer and Blood Disorders Service: Oncohematologia Pediàtrica Phase: Fase IV Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase II, aleatorizado, doble ciego, controlado con placebo y de búsqueda de dosis para evaluar la eficacia y la seguridad de psireotida s.c en pacientes de hipoglucemia posbariatrica. Contact Protocol code: SOM230-RECAG-CL-0576 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Ciudin Mihai, Andreea Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Phase 3 randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy and safety of nipocalimab in pregnancies at risk for severe hemolyticdisease of the fetus and newborn (hdfn) - azalea Contact Protocol code: 80202135EBF3001 EudraCT code: No aplica Pathology: Embaràs, part i puerperi Principal investigator: Sánchez Durán, Maria Ángeles Research group: Medicina materna i fetal Service: Obstetrícia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 DoseLevels of NMD670 over 21 Days in Adult Patients with AChR//MuSK-Ab+Myasthenia Gravis' Contact Protocol code: NMD670-02-0002 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Juntas Morales, Raul Research group: Sistema nerviós perifèric Service: Neurologia Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO DE FASE IIIb, GLOBAL, MULTICÉNTRICO, ALEATORIZADO, CON ENMASCARAMIENTO PARA EL EVALUADOR VISUAL, PARA EVALUAR LA EFICACIA, SEGURIDAD Y FARMACOCINÉTICA DE RANIBIZUMAB ADMINISTRADO CON EL DISPOSITIVO “PORT DELIVERY SYSTEM” UTILIZANDO UNA PAUTA DE RECARGA CADA 36 SEMANAS, EN PACIENTES CON DEGENERACIÓN MACULAR ASOCIADA A LA EDAD NEOVASCULAR (VELODROME) Contact Protocol code: WR42221 EudraCT code: 2020-001313-20 Pathology: Malalties de l’ull i dels seus annexos Principal investigator: García Arumí, José Research group: Oftalmologia Service: Oftalmologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado, doble ciego, comparado con placebo y multicéntrico de lumateperona como terapia complementaria en el tratamiento de pacientes con trastorno depresivo mayor Contact Protocol code: ITI-007-505 EudraCT code: No aplica Pathology: Trastorns mentals i del comportament Principal investigator: Rodríguez Urrutia, Amanda Research group: Psychiatry, Mental Health and Addictions Service: Psychiatry Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Títol Complet Servicio de adquisición de imágenes de resonancia magnética de alto campo (7.0 T) en modelo animal, a cargo del Proyecto PI22/01709 del Grupo de Neurorradiologia de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient RESONANCIA MAGNÉTICA ALTO CAMPO (PI22/01709) Codi 24972560 Data publicació Tue, 9 Jul 2024 - 12:00 Documentos (enllaços) ANEXO 1.PCAP PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES PLIEGO DE CLÁUSULAS TÉCNICAS RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN PROPUESTA PROVISIONAL Y REQUERIMIENTO ACUERDO DE ADJUDICACIÓN Pagination First page « Previous page ‹ … Page 1414 Page 1415 Current page 1416 Page 1417 Page 1418 … Next page › Last page »
Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Scientific Project Manager_20240242 Codi 2024-242 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0242//2024_0242_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció ERN EuroBloodNet Projects Coordinator Codi 2024-243 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0243//2024_0243_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Childhood Cancer and Blood Disorders Descripció Project Manager_Registries Codi 2024-244 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0244//2024_0244_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Sat, 27 Jul 2024 - 12:00 Descripció Ethics Committees Administrative_20240245 Codi 2024-245 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0245//2024_0245_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Fri, 12 Jul 2024 - 12:00 Data de tancament Fri, 26 Jul 2024 - 12:00 Grup de recerca Microbiome Research Descripció Research Technician Microbiome Research Group _20240246 Codi 2024-246 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0246//2024_0246_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Thu, 25 Jul 2024 - 12:00 Grup de recerca Rheumatology Descripció Clinical Research Monitor Rheumatology Research Group _20240240 Codi 2024-240 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0240//2024_0240_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Sun, 8 Sep 2024 - 12:00 Grup de recerca Basic, Translational and Clinical Pharmacy Research Descripció Call for Postdoctoral Junior Leader fellowships (Basic,Translational and Clinical Pharmacy Research Group)_20240241 Codi 2024-241 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0241//2024_0241_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Thu, 11 Jul 2024 - 12:00 Data de tancament Thu, 25 Jul 2024 - 12:00 Descripció Biddings Manager_20240239 Codi 2024-239 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0239//2024_0239_001.pdf Reclutant Inactiu
Year 2024 Títol Complet Servicio de adquisición de imágenes de resonancia magnética de alto campo (7.0 T) en modelo animal, a cargo del Proyecto PI22/01709 del Grupo de Neurorradiologia de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient RESONANCIA MAGNÉTICA ALTO CAMPO (PI22/01709) Codi 24972560 Data publicació Tue, 9 Jul 2024 - 12:00 Documentos (enllaços) ANEXO 1.PCAP PRINCIPALES PUNTOS SOBRE DIGITAL DEUC DEUC FORMATO XML INSTRUCCIONES PARA RELLENAR EL DEUC ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES PLIEGO DE CLÁUSULAS TÉCNICAS RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN PROPUESTA PROVISIONAL Y REQUERIMIENTO ACUERDO DE ADJUDICACIÓN
